Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Susan Wong

Showing results (121-130 of 148) with videos related to

Pageof 15
Sort By:
The Journal of Clinical Endocrinology and Metabolism|August 30, 2020
Altered Systemic and Intestinal IgA Immune Responses in Individuals With Type 1 DiabetesJuan Huang, Gan Huang, Xia Li, et al.
Diabetes|February 24, 2019
Altered Gut Microbiota Activate and Expand Insulin B15-23-Reactive CD8+ T CellsJames A Pearson, Dimitri Kakabadse, Joanne Davies, et al.
Frontiers in Immunology|March 13, 2023
NLRP6 deficiency expands a novel CD103<sup>+</sup> B cell population that confers immune tolerance in NOD miceJames A Pearson, Jian Peng, Juan Huang, et al.
Frontiers in Immunology|December 5, 2019
Norovirus Changes Susceptibility to Type 1 Diabetes by Altering Intestinal Microbiota and Immune Cell FunctionsJames A Pearson, Ningwen Tai, Dilrukshi K Ekanayake-Alper, et al.
Diabetologia|November 22, 2025
CXCR3 expression on antigen-experienced B cells is systemically dysregulated in type 1 diabetesJoanne Boldison, Pia Leete, Emma J Robinson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 23, 2017
Adoptive Transfer of mRNA-Transfected T Cells Redirected against Diabetogenic CD8 T Cells Can Prevent DiabetesSigal Fishman, Mark D Lewis, L Khai Siew, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 20, 2007
CD86 has sustained costimulatory effects on CD8 T cellsIan J Thomas, Liliana G Petrich de Marquesini, Rommel Ravanan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2007
Altered B:9-23 insulin, when administered intranasally with cholera toxin adjuvant, suppresses the expression of insulin autoantibodies and prevents diabetesMasakazu Kobayashi, Norio Abiru, Takeshi Arakawa, et al.
Diabetes|November 6, 2020
TLR9 Deficiency in B Cells Promotes Immune Tolerance via Interleukin-10 in a Type 1 Diabetes Mouse ModelSha Sha, James A Pearson, Jian Peng, et al.
Nature Communications|May 18, 2024
Tlr9 deficiency in B cells leads to obesity by promoting inflammation and gut dysbiosisPai Wang, Xin Yang, Luyao Zhang, et al.
Pageof 15

Showing results (121-130 of 148) with videos related to

Sort By:
Pageof 15
The Journal of Clinical Endocrinology and Metabolism|August 30, 2020
Altered Systemic and Intestinal IgA Immune Responses in Individuals With Type 1 DiabetesJuan Huang, Gan Huang, Xia Li, et al.
Diabetes|February 24, 2019
Altered Gut Microbiota Activate and Expand Insulin B15-23-Reactive CD8+ T CellsJames A Pearson, Dimitri Kakabadse, Joanne Davies, et al.
Frontiers in Immunology|March 13, 2023
NLRP6 deficiency expands a novel CD103<sup>+</sup> B cell population that confers immune tolerance in NOD miceJames A Pearson, Jian Peng, Juan Huang, et al.
Frontiers in Immunology|December 5, 2019
Norovirus Changes Susceptibility to Type 1 Diabetes by Altering Intestinal Microbiota and Immune Cell FunctionsJames A Pearson, Ningwen Tai, Dilrukshi K Ekanayake-Alper, et al.
Diabetologia|November 22, 2025
CXCR3 expression on antigen-experienced B cells is systemically dysregulated in type 1 diabetesJoanne Boldison, Pia Leete, Emma J Robinson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 23, 2017
Adoptive Transfer of mRNA-Transfected T Cells Redirected against Diabetogenic CD8 T Cells Can Prevent DiabetesSigal Fishman, Mark D Lewis, L Khai Siew, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 20, 2007
CD86 has sustained costimulatory effects on CD8 T cellsIan J Thomas, Liliana G Petrich de Marquesini, Rommel Ravanan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2007
Altered B:9-23 insulin, when administered intranasally with cholera toxin adjuvant, suppresses the expression of insulin autoantibodies and prevents diabetesMasakazu Kobayashi, Norio Abiru, Takeshi Arakawa, et al.
Diabetes|November 6, 2020
TLR9 Deficiency in B Cells Promotes Immune Tolerance via Interleukin-10 in a Type 1 Diabetes Mouse ModelSha Sha, James A Pearson, Jian Peng, et al.
Nature Communications|May 18, 2024
Tlr9 deficiency in B cells leads to obesity by promoting inflammation and gut dysbiosisPai Wang, Xin Yang, Luyao Zhang, et al.
Pageof 15